CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
BuruliVac aims to develop a vaccine against Buruli ulcer disease, caused by Mycobacterium ulcerans, which primarily affects children in rural areas. The project combines research in immunology and molecular genetics to identify and test new vaccine candidates.
Buruli ulcer disease (BUD), caused by Mycobacterium ulcerans, is a neglected bacterial infection of the poor in remote rural areas, mostly affecting children. BUD, the third most common mycobacterial disease in immunocompetent humans after tuberculosis and leprosy, is most endemic in West Africa, but cases have been reported from more than 30 countries. BUD is a mutilating disease leading to severe disability.
Treatment with antibiotics is possible but is long-lasting and requires injections, sh…
BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, MUNCHEN
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Belgium, ANTWERPEN
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
SWISS TPH SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE
Switzerland, Allschwil
Type: Research institute
Activity type: Research Organisations
SME: No
ST GEORGE'S HOSPITAL MEDICAL SCHOOL
United Kingdom, London
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
